Quantcast

Latest pharmaceutical industry Stories

2014-09-08 12:24:43

New report reveals positive outlook for pharmaceutical industry and key insights into current trends PHILADELPHIA, Sept. 8, 2014 /PRNewswire/ -- The Intellectual Property and Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today released its annual synopsis of pharmaceutical industry trends in its 2014 Pharmaceutical R&D Factbook, compiled by CMR International, a Thomson Reuters business and world leader in...

2014-09-08 08:31:56

ELLICOTT CITY, Md., Sept. 8, 2014 /PRNewswire/ -- RxTrials, a leading international Investigative Site Network (ISN) and consulting firm, has named Yvonne McCracken, MPH to the position of Vice President of Clinical Operations and Compliance. McCracken, who has 22 years' experience owning and managing sites, will be responsible for ensuring ongoing operational excellence from RxTrials' network of 15 sites in a diverse range of specialty areas. "Yvonne is a very well-known and...

2014-09-08 08:31:07

BOSTON, Sept. 8, 2014 /PRNewswire/ -- Columbia Laboratories, Inc. (Nasdaq: CBRX) ("Columbia" or "the Company"), a provider of pharmaceutical development, clinical trial manufacturing, and advanced analytical and consulting services to the pharmaceutical industry, today announced that Merck Serono has completed a routine license renewal for CRINONE in one of its biggest markets. CRINONE is Columbia's largest revenue stream and shipments to this high-growth, high-volume market were...

2014-09-08 08:31:01

BETHESDA, Md., Sept. 8, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that Linda F. Powers, CEO, will present at 2:05 pm on Tuesday, September 9, 2014, in the Holmes I Salon at the Palace Hotel in New York as part of the Rodman & Renshaw 16(th) Annual Global Investment Conference. http://photos.prnewswire.com/prnvar/20110329/SF73084LOGO...

2014-09-08 08:30:23

SAN DIEGO, Sept. 8, 2014 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (Nasdaq: IMMY), a specialty pharmaceutical company dedicated to delivering high quality and novel medicines to physicians and patients at accessible prices, today announced the appointment of William H. Nelson to its Board of Directors, effective September 4, 2014. Mr. Nelson served as the President and Chief Executive Officer of Intermountain Healthcare, an integrated nonprofit healthcare system with 160...

2014-09-08 08:30:20

- Data show improvements in hemodynamic parameters and exercise capacity SAN DIEGO, Sept. 8, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today reported top-line results from a Phase 2 study of AIR001 (sodium nitrite) inhalation solution for the treatment of pulmonary arterial hypertension (PAH). Mast obtained the rights to the AIR001 program through its acquisition of privately-held Aires Pharmaceuticals, Inc. earlier this year. In the primary efficacy analysis...

2014-09-08 08:29:59

Neuroscience Catalyst to Focus on Mood Disorders and Alzheimer's Disease TORONTO, Sept. 8, 2014 /CNW/ - Janssen Inc. (Janssen) today announced it has signed an agreement, facilitated by the Johnson & Johnson Innovation center in California, with the University of Toronto's Centre for Collaborative Drug Research (CCDR) to form an open-source collaboration focused on novel therapeutic approaches to the treatment and management of mood disorders and Alzheimer's disease. The...

2014-09-08 08:29:23

Immune Pharmaceuticals Recently Uplisted to NASDAQ Capital Market CAMBRIDGE, Mass. and HERZLIYA-PITUACH, Israel, Sept. 8, 2014 /PRNewswire/ -- Immune Pharmaceuticals Inc. (NASDAQ and NASDAQ OMX First North Premier, Stockholm: "IMNP"; "Immune" or "the Company"), today announced it will be featured as a presenting company at the 16(th) Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held September 8-10,...

2014-09-08 08:28:55

SOUTH SAN FRANCISCO, Calif., Sept. 8, 2014 /PRNewswire/ -- Velocity Pharmaceutical Development, LLC ("VPD"), a company that creates, invests in, and manages a portfolio of project focused companies, each of which contains a single drug candidate acquired from a third party, today announced that David J. Collier, MD, the company's Chief Executive Officer, will moderate a panel discussion at the seventh annual BioPharm America International Partnering Conference, to be held September...

2014-09-07 23:02:25

California Pacific Medical Center Research Institute investigators and colleagues provide a snapshot of registered clinical trials and a scorecard of publicly available results San Francisco, CA (PRWEB) September 07, 2014 Results from 40 percent of clinical trials for migraine on the world’s registries are not readily available more than two years after study completion, according to a thorough analysis and scorecard for public availability of results. Global findings from the...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'